HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Overexpression of phosphatidylethanolamine-binding protein 4 (PEBP4) associates with recurrence of meningiomas.

AbstractBACKGROUND AND PURPOSE:
Abnormal expression of phosphatidylethanolamine-binding protein 4 (PEBP4) has been identified in various types of malignant tumors. In the present study, we investigated the expression of PEBP4 in meningioma cases and examined whether PEBP4 expression was correlated with outcomes among these patients.
MATERIALS AND METHODS:
The expression levels of PEBP4 and Ki-67 in human meningioma tissues from 65 patients were evaluated by immunohistochemical staining. The correlation between PEBP4 immunoreactivity in meningioma samples and patients' clinical outcomes was examined using the Kruskal-Wallis correlation test. The prognostic value of PEBP4 expression in meningiomas patients also was investigated.
RESULTS:
Immunohistochemical analysis revealed up-regulated PEBP4 expression in both atypical and anaplastic meningiomas compared with classical meningiomas (13.38 ± 4.19% vs. 3.64 ± 2.04%, P < 0.001). PEBP4 immunoreactivity in meningioma samples was closely correlated with that for Ki-67 (Spearman r = 0.7922, P < 0.0001). PEBP4 expression was also associated with tumor differentiation grade and clinical recurrence (P < 0.05). Multivariate regression analysis showed with high PEBP4 expression was associated with a longer recurrence-free survival (hazard ratio=0.252, 95% confidence interval: 0.067-0.940, P = 0.040).
CONCLUSION:
PEBP4 may play an important role in the progression of meningioma, as high PEBP4 expression was associated with a higher pathological grade of meningioma. Moreover, PEBP4 expression may be a meaningful prognostic biomarker in meningioma.
AuthorsRen-Qiang Huang, Feng Chen, Ying-Bo Jiang, Yu-Ming Jin, Song-Qing Wang, Hai-Hui Liang, Zhi-Peng Chen, Jun Qian
JournalClinical neurology and neurosurgery (Clin Neurol Neurosurg) Vol. 214 Pg. 107148 (03 2022) ISSN: 1872-6968 [Electronic] Netherlands
PMID35158167 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2022 Elsevier B.V. All rights reserved.
Chemical References
  • Ki-67 Antigen
  • PE-binding protein 4, human
  • Phosphatidylethanolamine Binding Protein
Topics
  • Humans
  • Ki-67 Antigen (metabolism)
  • Meningeal Neoplasms (pathology)
  • Meningioma (pathology)
  • Neoplasm Recurrence, Local (pathology)
  • Phosphatidylethanolamine Binding Protein (metabolism)
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: